ICMRA SARS-CoV-2 Vaccines Workshop #2 – Summary
The International Coalition of Medicines Regulatory Authorities (ICMRA) published a report summarising its second workshop on the development of COVID-19 vaccines. The report highlights key considerations and data requirements for the design and conduct of phase 3 clinical trials. Read the Summary>>>